Signalling in pancreatic cancer: from pathways to therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Signalling in pancreatic cancer: from pathways to therapy

Published:2023-10-26 Issue:10 Volume:31 Page:1013-1026
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Zhou Kexun¹,Liu Yingping²,Yuan Shiman³,Zhou Ziyu²,Ji Pengfei²,Huang Qianhan⁴,Wen Feng¹,Li Qiu¹

Affiliation:

1. Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

2. The Second Clinical Medical College of Lanzhou University, Lanzhou University, Lanzhou, China

3. Guizhou Medical University, Guizhou, China

4. School of Public Health, Xuzhou Medical University, Xuzhou, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2023.2274806

Reference169 articles.

1. Pancreatic Cancer

2. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

3. Pancreatitis initiated pancreatic ductal adenocarcinoma: Pathophysiology explaining clinical evidence

4. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review

5. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer;Molecular Pharmaceutics;2024-07-25

2. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target;Journal of Cancer Research and Clinical Oncology;2024-03-14

3. To Investigate the Causal Relationship between Rheumatological Diseases and Pancreatic Cancer Risk Based on Mendelian Randomization;Advances in Clinical Medicine;2024

4. Phytochemicals in Pancreatic Cancer Treatment: A Machine Learning Study;ACS Omega;2023-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3